Estados financieros detallados de Rezolute, Inc. (RZLT): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $3.98, RZLT presenta beneficios negativos (P/E no significativo) y un ROE del -58.82%. La capitalización bursátil es de $383M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $8.3M | $12.6M | $1.1M | $48000 | $18000 | $13000 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$8.3M | -$12.6M | -$1.1M | -$48000 | -$18000 | -$13000 | 0 | 0 | 0 | 0 |
| I+D | $9.4M | $12.1M | $17.3M | $19.1M | $14.4M | $15.0M | $32.5M | $43.8M | $55.7M | $61.5M |
| Generales y Administrativos | $5.5M | $8.2M | $9.1M | $6.8M | $6.1M | $7.9M | $9.4M | $12.2M | $14.7M | $18.4M |
| Gastos Operativos | $15.0M | $20.3M | $26.4M | $25.9M | $20.5M | $22.9M | $41.8M | $56.0M | $70.4M | $79.9M |
| Beneficio Operativo | -$15.0M | -$20.3M | -$28.7M | -$25.9M | -$20.5M | -$22.9M | -$41.8M | -$56.0M | -$70.4M | -$79.9M |
| EBITDA | -$14.2M | -$19.2M | -$28.1M | -$25.4M | -$20.3M | -$20.5M | -$39.2M | -$51.8M | -$68.4M | -$74.4M |
| Gastos por Intereses | $5039 | $1595 | $689188 | $5.0M | 0 | $375000 | $1.8M | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$14.9M | -$20.3M | -$29.9M | -$30.4M | -$20.3M | -$20.9M | -$41.1M | -$51.8M | -$68.5M | -$74.4M |
| Impuestos | -$19822 | -$11367 | 0 | -$29000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$14.9M | -$20.3M | -$29.9M | -$30.4M | -$20.3M | -$20.9M | -$41.1M | -$51.8M | -$68.5M | -$74.4M |
| BPA | $-30.14 | $-24.55 | $-26.83 | $-17.11 | $-3.54 | $-2.72 | $-2.26 | $-1.01 | $-1.33 | $-0.98 |
| BPA Diluido | $-30.14 | $-24.55 | $-26.83 | $-17.11 | $-3.54 | $-2.72 | $-2.32 | $-1.01 | $-1.33 | $-0.98 |
| Acciones en Circulación (Diluidas) | $495464 | $825934 | $1.1M | $1.8M | $5.8M | $7.7M | $19.5M | $51.2M | $51.5M | $76.0M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | -$8000 | -$7000 | -$8000 |
| Beneficio Operativo | -$25.9M | -$19.8M | -$24.2M | -$17.4M |
| EBITDA | -$24.4M | -$18.1M | -$22.8M | -$16.2M |
| Beneficio Neto | -$24.4M | -$18.1M | -$22.8M | -$16.2M |
| BPA | $-0.26 | $-0.18 | $-0.22 | $-0.16 |
| BPA Diluido | $-0.26 | $-0.18 | $-0.22 | $-0.16 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $4.1M | $4.5M | $1.6M | $11.6M | $10.0M | $41.0M | $150.4M | $16.0M | $70.4M | $94.1M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $85.9M | $56.5M | $73.8M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $4.5M | $4.9M | $2.0M | $12.1M | $10.5M | $42.0M | $152.1M | $104.9M | $128.7M | $171.1M |
| Inmovilizado Material | $6.0M | $5.3M | $368374 | $44000 | $416000 | $425000 | $168000 | $2.2M | $2.0M | $1.4M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $51614 | $44322 | $37030 | $29000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $10.9M | $10.6M | $2.5M | $12.3M | $11.0M | $42.6M | $152.4M | $123.7M | $132.7M | $175.5M |
| Cuentas por Pagar | $1.5M | $926039 | $1.7M | $563000 | $893000 | $1.0M | $1.1M | $3.3M | $4.9M | $5.8M |
| Deuda a Corto | $83128 | $10000 | $3.4M | $10000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $1.7M | $1.8M | $6.2M | $8.4M | $3.2M | $2.0M | $2.5M | $5.2M | $9.6M | $11.9M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | $14.0M | 0 | 0 | 0 | 0 |
| Pasivos Totales | $2.1M | $2.1M | $6.5M | $10.5M | $3.6M | $16.5M | $2.9M | $7.5M | $11.7M | $13.4M |
| Reservas | -$44.0M | -$64.3M | -$94.2M | -$126.9M | -$147.2M | -$168.1M | -$209.2M | -$261.0M | -$329.4M | -$403.9M |
| Patrimonio Neto | $8.8M | $8.5M | -$4.0M | $1.8M | $7.4M | $26.1M | $149.5M | $116.2M | $121.0M | $162.1M |
| Deuda Total | $83128 | $10000 | $3.4M | $10000 | $410000 | $14.4M | $188000 | $2.5M | $2.2M | $1.6M |
| Deuda Neta | -$4.0M | -$4.5M | $1.8M | -$11.6M | -$9.5M | -$26.6M | -$150.2M | -$99.4M | -$124.6M | -$166.2M |
| Capital Circulante | $2.8M | $3.2M | -$4.2M | $3.8M | $7.3M | $40.0M | $149.6M | $99.7M | $119.0M | $159.2M |
Balance (Trimestral)
| Año | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 |
|---|
| Caja y Equivalentes | $94.1M | $9.1M | $11.9M | $11.2M |
| Activos Totales | $175.5M | $158.7M | $138.6M | $125.5M |
| Pasivos Totales | $13.4M | $11.5M | $10.6M | $8.6M |
| Patrimonio Neto | $162.1M | $147.2M | $128.0M | $116.8M |
| Deuda Total | $1.6M | $1.5M | $1.3M | $1.1M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$14.9M | -$20.3M | -$29.9M | -$30.4M | -$20.3M | -$20.9M | -$41.1M | -$51.8M | -$68.5M | -$74.4M |
| Amortizaciones | $751254 | $1.1M | $1.1M | $49000 | $18000 | $13000 | $13000 | $30000 | $36000 | $31000 |
| Compensación en Acciones | $3.8M | $6.0M | $5.1M | $2.6M | $3.3M | $4.0M | $3.7M | $7.3M | $7.4M | $7.1M |
| Cambio en Capital Circulante | -$119197 | -$155364 | $1.0M | $8.4M | -$7.5M | -$2.1M | -$642000 | $1.0M | $3.1M | $47000 |
| Flujo de Caja Operativo | -$10.5M | -$13.3M | -$14.1M | -$15.3M | -$24.2M | -$20.4M | -$39.6M | -$44.5M | -$57.4M | -$69.1M |
| Inversiones (CapEx) | -$2.1M | -$407929 | -$5816 | -$47000 | 0 | 0 | 0 | -$153000 | 0 | 0 |
| Adquisiciones | 0 | 0 | $1.6M | $278000 | 0 | 0 | 0 | $101.5M | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$12.6M | -$13.7M | -$14.1M | -$15.4M | -$24.2M | -$20.4M | -$39.6M | -$44.6M | -$57.4M | -$69.1M |
Flujo de Caja (Trimestral)
| Año | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 |
|---|
| Flujo de Caja Operativo | -$22.0M | -$17.4M | -$20.3M | -$13.7M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$22.0M | -$17.4M | -$20.3M | -$13.7M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $2.4M | $2.5M | $3.4M | $4.4M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | -35.8% | -47.3% | -1.9% | +33.2% | -2.8% | -96.4% | -26.1% | -32.2% | -8.7% |
| Crecimiento BPA (anual) | | +18.5% | -9.3% | +36.2% | +79.3% | +23.2% | +16.9% | +55.3% | -31.7% | +26.3% |
| Cambio en Acciones (anual) | | +66.7% | +34.8% | +59.7% | +223.6% | +33.4% | +154.0% | +162.7% | +0.5% | +47.7% |
| Crecimiento FCF (anual) | | -9.1% | -2.9% | -8.7% | -57.4% | +15.4% | -93.8% | -12.7% | -28.5% | -20.4% |
| Tasa Impositiva Efectiva | 0.1% | 0.1% | -0.0% | 0.1% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-25.39 | $-16.61 | $-12.68 | $-8.64 | $-4.20 | $-2.66 | $-2.03 | $-0.87 | $-1.11 | $-0.91 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $495464 | $825934 | $1.1M | $1.8M | $5.8M | $7.7M | $18.2M | $51.2M | $51.5M | $76.0M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -58.82% |
| Rentabilidad sobre capital invertido | -73.68% |
| Rentabilidad sobre activos | -64.95% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 15.84 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 11.58 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -1.66 | -2.30 | -0.84 | -0.58 | -1.31 | -5.25 | -1.43 | -1.96 | -3.24 | -4.55 |
| P/VC | 2.82 | 5.47 | -6.32 | 10.04 | 3.63 | 4.19 | 0.39 | 0.87 | 1.83 | 2.09 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |